Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Venture Life ( (GB:VLG) ) has provided an update.
Venture Life Group PLC has announced the issuance of 1,000,000 new ordinary shares following the exercise of share options, with trading on AIM expected to commence on January 24, 2025. This increases the total number of ordinary shares and voting rights to 128,052,312, impacting shareholder calculations under FCA rules.
More about Venture Life
Venture Life Group PLC is an international consumer self-care company that develops, manufactures, and commercializes products for the global self-care market. It operates in the UK, Italy, The Netherlands, and Sweden, offering a diverse product portfolio including oral care, women’s intimate healthcare, hypoglycemia treatment, oncology support, ear wax removal, fungal infection treatments, and anti-aging dermo-cosmetics. The group’s products are available in over 90 countries, mainly through pharmacies and grocery stores, and it also provides development and manufacturing services in the medical devices and cosmetic sectors.
YTD Price Performance: -7.01%
Average Trading Volume: 195,103
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £46.37M
See more insights into VLG stock on TipRanks’ Stock Analysis page.
